合成龙脑与合成樟脑制备新工艺初探

报道了一种制备合成龙脑与合成樟脑的新工艺。常压下异龙脑在一种含锌催化剂作用下 ,可部分脱氢生成樟脑 ,部分异构化生成龙脑。将此产物分离提纯后可同时得到合成樟脑与合成龙脑     

冰片中右旋龙脑及其异构体的手性毛细管气相色谱法测定

以CYDEX -B手性毛细管柱 (25m×0.22mm,0.25μm)作为分析柱,用气相色谱法和气相色谱 -质谱联用法对天然冰片、艾片和合成冰片进行测定。合成冰片中的左旋龙脑与右旋龙脑可完全分离 ,左旋异龙脑与右旋异龙脑可部分分离。实验测得 :天然冰片中右旋龙脑的含量为99.13%～99.61 %;艾片中左旋龙脑的含量为95.87 %;合成冰片中左旋龙脑的含量为31.44 %～54.57 %,右旋龙脑的含量6.87 %～25.37 %;合成冰片的比旋度 α30D 为 -17.3°～ -2.3°。     

三梅片成份分析研究

医药品冰片有天然品与合成品之分,天然品有:由龙脑香科(Dipterocarpaceae)植物龙脑香(Dryobalanops aromatica G aertn,f.)制得的结晶,称龙脑香冰片;白菊科(Compositae)植物艾纳香(Blumea balsamifera DC.)所得的结晶,名艾片。艾片因其晶形似梅花片,又有梅片之称,根据梅花片状又分为大梅片,二梅片,三梅片,天然品化学成分为龙脑(Borneol,Ⅰ),合成冰片(又名合成龙脑),除含龙脑外尚含较大量的异龙脑(ISO-borneol,Ⅱ)     

龙脑合成方法的改进

龙脑合成方法的改进;纳米固体超强酸; α-蒎烯; 草酸; 龙脑     

手性位移试剂Eu(dcm)~3的一个改进合成方法

我们对H(dcm)的Whitesides合成路线的关键步骤龙脑酰甲烷的合成和缩合反应进行了重要的改进。     

一步法合成龙脑的研究

在强酸性的固体酸催化作用下,龙脑可以从α-蒎烯一步合成。用此法合成的产物中含46％龙脑、11.7％α-松油醇和其它萜烯产物。此反应是立体选择性的,从产物中分离得到的龙脑仅含9.3％异龙脑。文中还考察了温度效应、蒎烯和催化剂及水的配比、溶剂效应、催化剂的寿命和再生等问题。     

新型α-龙脑烯醛基噻二唑-膦酸酯化合物的合成及其抑菌活性

以α-蒎烯为原料,经环氧化和催化异构反应得α-龙脑烯醛(3);3与氨基硫脲反应制得α-龙脑烯醛基缩氨基硫脲,再环合生成α-龙脑烯醛基噻二唑,最后将其与亚磷酸三苯酯和一系列醛通过类Mannich反应合成了11个新型α-龙脑烯醛基噻二唑-膦酸酯化合物(6a~6k),其结构经1H NMR,13C NMR,IR和ESI-MS表征。抑菌活性测试结果表明:在用药量为50μg·m L~(-1)时,6b对苹果轮纹病菌的抑制率为60.5%。     

丙氨酸的双不对称合成

氨基酸的不对称合成是近年来研究热点之一,双不对称合成新设想为高光学纯度物质的合成提供了一条有益的思路。本文考察在手性相转移催化条件下,邻苯二甲酰亚胺钾与手性α-溴代丙酸龙脑酯的Gabriel反应制取光学活性丙氨酸,观察到显著的双不对称诱导效应。 仪器为Perkin-Elmer 241MC型旋光仪、PE240-C型元素分析仪。邻苯二甲酰亚胺钾按文献[3]制备;α-溴代丙酸乙酯为上海试剂总厂产品,(一)-龙脑为贵州罗甸制药厂产品,[αj_D~(25)=—37.2,(C5,乙醇);α-溴代丙酸龙脑酯根据文献制备并经过元素分析和光谱鉴定。(一)-N-苄     

新手性化合物－龙脑基氨基醇的合成

以天然d-樟脑的衍生物为原料,合成了两种龙脑基氨基醇,其方法简单,化学收率高。对中间体及目标化合物结构及物理性质作了表征。     

(-)-龙脑手性离子液体的合成

以(-)-龙脑为手性源,与溴乙酰溴通过酯化反应合成溴代乙酸龙脑酯(2);2与4,4'-联吡啶发生取代反应引入两个手性中心制得新型手性离子液体——N,N'-双(龙脑氧甲酰亚甲基)联吡啶.二溴(3.2Br-);3.2Br-与四氟硼酸钾或六氟磷酸钾盐进行阴离子交换制得相应的手性离子液体3.2BF4-或3.PF6-.3.2Br...     

冰片及其酯/酰胺类衍生物的合成和活性研究进展

冰片是重要的芳香开窍类中药,具有开窍醒神,清热止痛等功效,常被作为佐药与其他中药配伍使用。目前,冰片及其衍生物广泛用于医药、农药、化工及香料领域,市场前景好,研究和开发价值高。本文对天然冰片、合成冰片及其酯/酰胺类衍生物的主要合成方法和生物活性方面进行了系统总结,并对冰片酯类衍生物未来的研究方向进行了展望,以期为冰片及其酯/酰胺类衍生物的进一步的研究提供有益参考。     

傅里叶变换红外光谱法在监测龙脑酯化反应中的应用

报道了用傅里叶变换红外光谱法定量分析龙脑 /硼酸龙脑酯和龙脑 /邻苯二甲酸酸性龙脑酯两个二元体系的测试方法。该方法具有简便、准确的特点。     

硼酸酯化法分离龙脑、异龙脑与樟脑

用硼酸与异龙脑的异构化产物—龙脑、异龙脑和樟脑的混合物进行反应，得到硼酸莰酯和樟脑。莰酯与樟脑分离后，经水解得到龙脑和异龙脑。     

3,5-二硝基苯甲酸冰片酯的合成及结构表征

冰片在中药中被广泛应用。利用前药原理,对冰片母体进行修饰,以冰片和3,5-二硝基苯甲酸为原料,以对甲苯磺酸为催化剂,合成了3,5-二硝基苯甲酸冰片酯,目标化合物的结构经FT-IR、13C NMR、1H NMR和元素分析加以确证。该化合物具有一定的研究开发价值。     

In vitro characterization of borneol metabolites by GC-MS upon incubation with rat liver microsomes

The metabolism of borneol is studied by the analysis of incubations of in vitro-prepared rat liver microsomes. A sensitive gas chromatography (GC)-mass spectrometry (MS) method is developed for the identification of borneol and its metabolites. Four novel metabolites, which have not previously been reported, are isolated and confirmed by comparison of the GC-MS method. The biotransformation pathway of borneol in rat liver microsomes is proposed based on the in vitro results.     

Preparation of Alum-borneol-PVP Drug-loaded Fibers by Electrospinning

The alum-borneol nanoemulsion(ABN), which combines the mineral medicine alum and the botanical medicine borneol, has been applied for approximately 40 years in the clinical treatment of burns, scalds, radiation dermatitis and shingles, and has a good curative effect. However, the current formula and dosage form of ABN pose problems of low borneol content and ease of precipitation, which greatly affects the efficacy of the drug. In this study, polyvinylpyrrolidone(PVP) was selected as a carrier mixed with different proportions of alum and borneol to produce alum-borneol-PVP fibers(ABPF) by electrospinning. The results showed that the stable system with good drug dispersion was 2:3(alum:borneol). The dissolution content of borneol from the ABPF was about 80% in 4 h, which was much higher than that of the alum-borneol liquid(ABL) and ABN. The ABPF membrane showed a more significant inhibitory effect on Staphylococcus aureus than the ABL and ABN. The composite fiber markedly increased the drug content of borneol, which was 800 times of that in ABN. The fiber had a higher solubility than the nanoemulsion in vitro, which is of great importance for the de-velopment of new forms for the clinical application of alum and borneol.     

The effect of camphor and borneol on rat thymocyte viability and oxidative stress

Camphor and borneol are wildly distributed in the essential oils of medicinal plants from various parts of the World. Our study has been carried out to evaluate the effect of these two bicyclic monoterpenes on rat thymocytes. Camphor and borneol at concentrations of 0.5 and 5 μg/mL did not induce significant toxicity on the immune system cells, while a significant increase of thymocyte viability was detected when cells were incubated with 50 μg/mL of camphor. A significant increase of cell viability was similarly detected when thymocytes were cultivated with borneol at concentrations of 0.5 and 5 μg/mL. The role of camphor and borneol in reactive oxygen species (ROS) production and mitochondrial membrane potential (MMP) disturbances in rat thymocytes as well as their potential mechanism(s) of action were also discussed.     

The effectiveness of borneol on pharmacokinetics changes of four ginsenosides in Shexiang Baoxin Pill in vivo

Shexiang Baoxin Pill (SBP) is a traditional Chinese medicine, widely used for cardiovascular diseases in the clinic. Ginsenosides are important effective components in SBP, but their pharmacokinetic characteristics are still not known. In this paper, we studied the pharmacokinetics of ginsenoside Rb1, Rc, Re and Rg1 in SBP and investigated the effect of borneol on the pharmacokinetic characteristic of ginsenosides based on an Agilent G6410A triple quadrupole LC/MS system. Results showed that the pharmacokinetic parameters of ginsenoside Rb1, Rc, Re and Rg1 in rat plasma after oral administration of SBP are significantly different with oral administration of SBP without Borneolum Syntheticum. Plasma pharmacokinetic profiles after oral administration of ginsenoside Rb1, Rc, Re, Rg1 and co‐administration with borneol at three different ratios (10:1, 1:1 and 1:10 ginsenoside vs borneol, w/w) were also determined. It was demonstrated that borneol can elevate the plasma concentration of ginsenosides after co‐admininstration. Copyright © 2013 John Wiley & Sons, Ltd.     

Enhancing effect of borneol on pharmacokinetics of ginsenoside Rb1, ginsenoside Rg1, and notoginsenoside R1 in healthy volunteers after oral administration of compound Danshen dropping pills

Borneol (Bingpian), a monoterpenoid pharmaceutical ingredient, is commonly used as a main composition in traditional Chinese medicine preparations such as compound Danshen dropping pills (CDDP) and has also been approved by the U.S. Food and Drug Administration as a flavoring substance or adjuvant in food. Borneol plays a regulating and guiding role as a messenger drug in CDDP. However, the effect of borneol on the pharmacokinetics of the components of CDDP in human plasma is unclear. In this study, we investigate the effects of borneol on the pharmacokinetics of ginsenoside Rb₁ (Rb₁), ginsenoside Rg₁ (Rg₁), and notoginsenoside R₁ (NR₁) in CDDP. We used a double-cycle crossover-administration model in 12 healthy male volunteers, administered CDDP with borneol (drug T) and without borneol (drug R). The selective response monitoring mode was used for MS quantification in the positive mode. As a result, we found that borneol could significantly affect the pharmacokinetic parameters of notoginsenosides and increase the absorption and systemic exposure of Rb₁, Rg₁, and NR₁ in human plasma by ~1.85–3.71 times.